190 related articles for article (PubMed ID: 2992212)
1. Immunocytochemical demonstration of S-phase cells by anti-bromodeoxyuridine monoclonal antibody in human brain tumor tissues.
Nagashima T; DeArmond SJ; Murovic J; Hoshino T
Acta Neuropathol; 1985; 67(1-2):155-9. PubMed ID: 2992212
[TBL] [Abstract][Full Text] [Related]
2. Cell kinetic studies of in situ human brain tumors with bromodeoxyuridine.
Hoshino T; Nagashima T; Murovic J; Levin EM; Levin VA; Rupp SM
Cytometry; 1985 Nov; 6(6):627-32. PubMed ID: 2998714
[TBL] [Abstract][Full Text] [Related]
3. [Immunohistochemical study of S-phase cells in human gliomas].
Ibayashi N; Hirakawa K; Suzuki K; Nakamura K; Houri T
No To Shinkei; 1988 Aug; 40(8):763-9. PubMed ID: 2460117
[TBL] [Abstract][Full Text] [Related]
4. Immunocytochemical demonstration of S phase cells by anti-bromodeoxyuridine monoclonal antibody in human prostate adenocarcinoma.
Nemoto R; Uchida K; Shimazui T; Hattori K; Koiso K; Harada M
J Urol; 1989 Feb; 141(2):337-40. PubMed ID: 2643726
[TBL] [Abstract][Full Text] [Related]
5. In vitro immunohistochemical localization of S-phase cells by a monoclonal antibody to bromodeoxyuridine.
Risio M; Coverlizza S; Poccardi G; Candelaresi GL; Gaiola O
Basic Appl Histochem; 1986; 30(4):469-77. PubMed ID: 3548696
[TBL] [Abstract][Full Text] [Related]
6. Proliferating cell nuclear antigen (PCNA) immunostaining as an alternative to bromodeoxyuridine (BrdU) immunostaining for brain tumours in paraffin embedded sections.
Sasaki A; Naganuma H; Kimura R; Isoe S; Nakano S; Nukui H; Suzuki K; Kawaoi A
Acta Neurochir (Wien); 1992; 117(3-4):178-81. PubMed ID: 1357920
[TBL] [Abstract][Full Text] [Related]
7. In situ analysis of cell kinetics in human brain tumors. A comparative immunocytochemical study of S phase cells by a new in vitro bromodeoxyuridine-labeling technique, and of proliferating pool cells by monoclonal antibody Ki-67.
Morimura T; Kitz K; Budka H
Acta Neuropathol; 1989; 77(3):276-82. PubMed ID: 2922990
[TBL] [Abstract][Full Text] [Related]
8. Immunohistochemical demonstration of S-phase cells by anti-bromodeoxyuridine monoclonal antibody in cattle tissues.
Yanai T; Matsumoto C; Takashima H; Yoshida K; Sakai H; Isowa K; Iwasaki T; Sato Y; Masegi T
J Comp Pathol; 1996 Apr; 114(3):265-72. PubMed ID: 8762584
[TBL] [Abstract][Full Text] [Related]
9. Double immunocytochemical labeling of cell and tissue samples with monoclonal anti-bromodeoxyuridine.
Magaud JP; Sargent I; Clarke PJ; Ffrench M; Rimokh R; Mason DY
J Histochem Cytochem; 1989 Oct; 37(10):1517-27. PubMed ID: 2476478
[TBL] [Abstract][Full Text] [Related]
10. In situ cell kinetics studies on human neuroectodermal tumors with bromodeoxyuridine labeling.
Hoshino T; Nagashima T; Murovic JA; Wilson CB; Edwards MS; Gutin PH; Davis RL; DeArmond SJ
J Neurosurg; 1986 Mar; 64(3):453-9. PubMed ID: 3950723
[TBL] [Abstract][Full Text] [Related]
11. Variability in the proliferative potential of human gliomas.
Hoshino T; Nagashima T; Cho KG; Davis RL; Donegan J; Slusarz M; Wilson CB
J Neurooncol; 1989 Jul; 7(2):137-43. PubMed ID: 2550593
[TBL] [Abstract][Full Text] [Related]
12. In situ demonstration of tissue proliferative activity using anti-bromo-deoxyuridine monoclonal antibody.
Veronese S; Gambacorta M; Falini B
J Clin Pathol; 1989 Aug; 42(8):820-6. PubMed ID: 2475528
[TBL] [Abstract][Full Text] [Related]
13. Immunocytochemical detection of S-phase cells in normal and neoplastic cervical epithelium by anti-BrdU monoclonal antibody.
Fukuda K; Iwasaka T; Hachisuga T; Sugimori H; Tsugitomi H; Mutoh F
Anal Quant Cytol Histol; 1990 Apr; 12(2):135-8. PubMed ID: 2350389
[TBL] [Abstract][Full Text] [Related]
14. Interaction of monoclonal antibodies directed against bromodeoxyuridine with pyrimidine bases, nucleosides, and DNA.
Miller MR; Heyneman C; Walker S; Ulrich RG
J Immunol; 1986 Mar; 136(5):1791-5. PubMed ID: 3950402
[TBL] [Abstract][Full Text] [Related]
15. The proliferative potential of human ependymomas measured by in situ bromodeoxyuridine labeling.
Nagashima T; Hoshino T; Cho KG; Edwards MS; Hudgins RJ; Davis RL
Cancer; 1988 Jun; 61(12):2433-8. PubMed ID: 3284636
[TBL] [Abstract][Full Text] [Related]
16. [A review of cell kinetic studies on brain tumors with special reference to anti-bromodeoxyuridine monoclonal antibody method].
Nagashima T; Hoshino T
No Shinkei Geka; 1984 Aug; 12(9):1007-18. PubMed ID: 6390240
[TBL] [Abstract][Full Text] [Related]
17. Proliferative potential of human meningiomas of the brain. A cell kinetics study with bromodeoxyuridine.
Hoshino T; Nagashima T; Murovic JA; Wilson CB; Davis RL
Cancer; 1986 Oct; 58(7):1466-72. PubMed ID: 2427189
[TBL] [Abstract][Full Text] [Related]
18. [Factors affecting the prognosis of brain tumors].
Yoshimine T; Hayakawa T; Mogami H
Gan To Kagaku Ryoho; 1988 Jul; 15(7):2022-7. PubMed ID: 2840033
[TBL] [Abstract][Full Text] [Related]
19. Rapid detection of S-phase cells by anti-bromodeoxyuridine monoclonal antibody in 9L brain tumor cells in vitro and in situ.
Nagashima T; Hoshino T
Acta Neuropathol; 1985; 66(1):12-7. PubMed ID: 3993331
[TBL] [Abstract][Full Text] [Related]
20. Pediatric central nervous system tumors: a cell kinetic study with bromodeoxyuridine.
Murovic JA; Nagashima T; Hoshino T; Edwards MS; Davis RL
Neurosurgery; 1986 Dec; 19(6):900-4. PubMed ID: 3027608
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]